Literature DB >> 30063981

Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations.

Romina Dieli-Crimi1, Mónica Martínez-Gallo1, Clara Franco-Jarava1, Maria Antolin2, Laura Blasco2, Ida Paramonov2, Maria E Semidey3, Antoni Álvarez Fernández4, Xavier Molero5, Julio Velásquez5, Andrea Martín-Nalda6, Ricardo Pujol-Borrell1, Roger Colobran7.   

Abstract

Monoallelic loss-of-function mutations in NFKB1 were recently recognized as the most common monogenic cause of common variable immunodeficiency (CVID). The prototypic clinical phenotype of NFKB1-deficient patients includes common CVID features, such as hypogammaglobulinaemia and sinopulmonary infections, plus other highly variable individual manifestations. Here, we describe a patient with a profound CVID phenotype and severe gastrointestinal manifestations, including chronic and recurrent diarrhoea. Using an NGS customized panel of 323 genes related to primary immunodeficiencies, we identified a novel monoallelic loss-of-function mutation in NFKB1 leading to a truncated protein (c.1149delT/p.Gly384Glu ∗ 48). Interestingly, we also found a rare variant in NOD2 previously associated with Crohn's disease (p.His352Arg). Our patient had hypogammaglobulinaemia with a small number of B cells, most of which were naïve. The most noteworthy findings included marked skewing towards a Th1 phenotype in peripheral blood T cells and excessive production of proinflammatory cytokines (IL-1β, TNFα). The patient's 6-year-old daughter, a carrier of the NFKB1 mutation, is clinically asymptomatic, but has started to show cellular and molecular changes. This case of NFKB1 deficiency appears to be a combination of immunodeficiency and a hyperinflammatory state. The current situation of the patient's daughter provides a glimpse of the preclinical phase of the condition.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoinflammation; Common Variable Immunodeficiency; Enteropathy; NF-κB pathway; NFKB1; NOD2; Next Generation Sequencing; Primary Immunodeficiency; Th1 cells

Mesh:

Substances:

Year:  2018        PMID: 30063981     DOI: 10.1016/j.clim.2018.07.015

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  11 in total

1.  Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report.

Authors:  Clara Franco-Jarava; Irene Valenzuela; Jacques G Riviere; Marina Garcia-Prat; Mónica Martínez-Gallo; Romina Dieli-Crimi; Neus Castells; Laura Batlle-Masó; Pere Soler-Palacin; Roger Colobran
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

2.  SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome.

Authors:  Darja Kanduc
Journal:  Glob Med Genet       Date:  2022-07-14

3.  Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity.

Authors:  Eun Sil Kim; Dongsub Kim; Yoonsun Yoon; Yiyoung Kwon; Sangwoo Park; Jihyun Kim; Kang Mo Ahn; Soomin Ahn; Yon Ho Choe; Yae-Jean Kim; Mi Jin Kim
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

4.  A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage.

Authors:  Manfred Fliegauf; Renate Krüger; Sophie Steiner; Leif Gunnar Hanitsch; Sarah Büchel; Volker Wahn; Horst von Bernuth; Bodo Grimbacher
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

5.  First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Years' Experience in Catalonia (Spain).

Authors:  Ana Argudo-Ramírez; Andrea Martín-Nalda; Jose L Marín-Soria; Rosa M López-Galera; Sonia Pajares-García; Jose M González de Aledo-Castillo; Mónica Martínez-Gallo; Marina García-Prat; Roger Colobran; Jacques G Riviere; Yania Quintero; Tatiana Collado; Judit García-Villoria; Antonia Ribes; Pere Soler-Palacín
Journal:  Front Immunol       Date:  2019-10-22       Impact factor: 7.561

Review 6.  Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity.

Authors:  Jessica D Gereige; Paul J Maglione
Journal:  Front Immunol       Date:  2019-12-10       Impact factor: 7.561

7.  Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency. Two years' experience in Catalonia (Spain).

Authors:  Andrea Martin-Nalda; Anna M Cueto-González; Ana Argudo-Ramírez; Jose L Marin-Soria; Monica Martinez-Gallo; Roger Colobran; Albert Plaja; Neus Castells; Jacques Riviere; Eduardo F Tizzano; Pere Soler-Palacin
Journal:  Mol Genet Genomic Med       Date:  2019-10-30       Impact factor: 2.183

Review 8.  Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.

Authors:  Hui Yu; Liangbin Lin; Zhiqiang Zhang; Huiyuan Zhang; Hongbo Hu
Journal:  Signal Transduct Target Ther       Date:  2020-09-21

9.  Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.

Authors:  Jean-Laurent Casanova; Qian Zhang; Bertrand Boisson; Juan Li; Wei-Te Lei; Peng Zhang; Franck Rapaport; Yoann Seeleuthner; Bingnan Lyu; Takaki Asano; Jérémie Rosain; Boualem Hammadi; Yu Zhang; Simon J Pelham; András N Spaan; Mélanie Migaud; David Hum; Benedetta Bigio; Maya Chrabieh; Vivien Béziat; Jacinta Bustamante; Shen-Ying Zhang; Emmanuelle Jouanguy; Stephanie Boisson-Dupuis; Jamila El Baghdadi; Vishukumar Aimanianda; Katharina Thoma; Manfred Fliegauf; Bodo Grimbacher; Anne-Sophie Korganow; Carol Saunders; V Koneti Rao; Gulbu Uzel; Alexandra F Freeman; Steven M Holland; Helen C Su; Charlotte Cunningham-Rundles; Claire Fieschi; Laurent Abel; Anne Puel; Aurélie Cobat
Journal:  J Exp Med       Date:  2021-09-02       Impact factor: 14.307

10.  Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of NFKB1 Knockout THP1 Cells.

Authors:  Domenico Somma; Fatma O Kok; David Kerrigan; Christine A Wells; Ruaidhrí J Carmody
Journal:  Front Immunol       Date:  2021-10-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.